B+
Bull case
30%
Probability
Target price
$67.00
Analysis reference price unavailable
Analysis 2026-09-14 · RankAlpha Sentiment Codex
COO
Cooper CompaniesCNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Q3 non-GAAP EPS rose 4% to $1.15, free cash flow increased 66% to $273.0 million, non-GAAP operating margin expanded 30 basis points, and the company repurchased $339.1 million of stock. If destocking proves temporary, premium lenses, fertility growth and capital returns could drive recovery.
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.3.
What can break
Asia-Pacific CooperVision revenue declined 5% organically amid portfolio rationalization and softer market conditions.
Momentum
23
Value
63
Sentiment
43
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $57.00 · Bull $67.00 · Bear $44.00Analysis 2026-09-14; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-26 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-14 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $65.43
Why
Momentum23 · Δ7d +19.3
Value63 · Δ7d -0.3
Sentiment43 · Δ7d -5.5
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.3.
Contradictions & invalidation
- • Asia-Pacific CooperVision revenue declined 5% organically amid portfolio rationalization and softer market conditions.
- • Continued U.S. channel destocking may depress Q4 CooperVision sales and obscure underlying consumption trends. [#SEC-8K-2026-09-09]
- • Revenue of $1.066 billion missed the cited consensus by 3%, CooperVision revenue was flat, Americas organic revenue fell 2%, and management expects inventory actions to continue weighing on Q4.
Catalyst clock
2026-10-31
U.S. channel destocking remains a Q4 headwind
Lead driver: Value · See fundamentals
Momentum
23
8% active weight
Current posture
7d trendImproving
Δ7d
+19.3
Δ21d
+24.3
Value
63
47% active weight
Current posture
7d trendFlat
Δ7d
-0.3
Δ21d
-0.5
Sentiment
43
45% active weight
Current posture
7d trendSoftening
Δ7d
-5.5
Δ21d
-14.7
Why this grade
Composite grade C. Momentum 22.7 / Value 63.0 / Sentiment 43.3
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-14. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$57.00
Analysis reference price unavailable
Analysis 2026-09-14 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$44.00
Analysis reference price unavailable
Analysis 2026-09-14 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-26
Fundamentals (TTM)
As of 2026-10-26
Market Cap
$11.63B
Beta
1.03
Shares Out
190.16M
P/E (TTM)
44.2
P/S (TTM)
3.96
P/FCF (TTM)
37.39
Rev YoY
+7.9%
EPS YoY
-191.4%
Gross Margin
+60.9%
Op Margin
+18.2%
Net Debt
$2.67B
Current Ratio
1.27
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data